Lord, Abbett & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$362M Buy
1,482,192
+152,507
+11% +$35.5M 1.18% 10
2025
Q4
$275M Buy
1,329,685
+191,239
+17% +$37.8M 0.84% 24
2025
Q3
$211M Buy
1,138,446
+569,700
+100% +$97.6M 0.63% 38
2025
Q2
$86.9M Sell
568,746
-137,353
-19% -$21.1M 0.28% 98
2025
Q1
$117M Buy
706,099
+274,905
+64% +$43M 0.42% 66
2024
Q4
$62.4M Buy
431,194
+128
+0% +$19.8K 0.2% 137
2024
Q3
$69.9M Buy
+431,066
New +$68.7M 0.22% 135
2021
Q2
Sell
-105,242
Closed -$17.3M 670
2021
Q1
$17.3M Sell
105,242
-699,156
-87% -$113M 0.04% 432
2020
Q4
$127M Sell
804,398
-343,886
-30% -$50.7M 0.33% 87
2020
Q3
$171M Sell
1,148,284
-301,697
-21% -$44.6M 0.55% 35
2020
Q2
$204M Buy
1,449,981
+241,850
+20% +$35.2M 0.71% 10
2020
Q1
$158M Buy
1,208,131
+23,219
+2% +$3.29M 0.7% 15
2019
Q4
$173M Sell
1,184,912
-27,419
-2% -$3.72M 0.58% 21
2019
Q3
$157M Sell
1,212,331
-287,702
-19% -$37.9M 0.53% 26
2019
Q2
$209M Sell
1,500,033
-671,540
-31% -$93M 0.68% 10
2019
Q1
$304M Buy
2,171,573
+121,137
+6% +$16.2M 1.01% 3
2018
Q4
$265M Sell
2,050,436
-163,147
-7% -$22.8M 0.97% 7
2018
Q3
$306M Buy
2,213,583
+149,748
+7% +$19.9M 0.85% 6
2018
Q2
$250M Sell
2,063,835
-464,515
-18% -$58M 0.73% 9
2018
Q1
$324M Buy
2,528,350
+246,437
+11% +$33.3M 0.96% 4
2017
Q4
$319M Buy
2,281,913
+39,110
+2% +$5.45M 0.91% 4
2017
Q3
$292M Sell
2,242,803
-253,597
-10% -$33.6M 0.85% 5
2017
Q2
$330M Sell
2,496,400
-148,544
-6% -$18.9M 0.98% 4
2017
Q1
$329M Sell
2,644,944
-56,856
-2% -$6.79M 0.99% 5
2016
Q4
$311M Sell
2,701,800
-286,251
-10% -$33.1M 0.95% 6
2016
Q3
$353M Sell
2,988,051
-663,887
-18% -$80.5M 1.08% 4
2016
Q2
$443M Buy
3,651,938
+489,286
+15% +$55.6M 1.39% 2
2016
Q1
$342M Buy
3,162,652
+1,429,110
+82% +$148M 1.08% 5
2015
Q4
$178M Sell
1,733,542
-892,840
-34% -$89.8M 0.54% 23
2015
Q3
$245M Buy
2,626,382
+753,779
+40% +$72.9M 0.74% 8
2015
Q2
$183M Sell
1,872,603
-214,500
-10% -$21.5M 0.48% 26
2015
Q1
$210M Buy
2,087,103
+691,853
+50% +$70.4M 0.53% 23
2014
Q4
$146M Buy
1,395,250
+383,031
+38% +$40.4M 0.37% 63
2014
Q3
$108M Sell
1,012,219
-385,496
-28% -$40M 0.27% 90
2014
Q2
$146M Buy
1,397,715
+643,783
+85% +$65.1M 0.33% 76
2014
Q1
$74.1M Sell
753,932
-119,511
-14% -$11.1M 0.17% 169
2013
Q4
$80M Sell
873,443
-298,221
-25% -$27.5M 0.18% 161
2013
Q3
$101M Sell
1,171,664
-727,262
-38% -$65.2M 0.23% 122
2013
Q2
$163M Buy
+1,898,926
New +$161M 0.38% 54

Other funds holding JNJ

Lord, Abbett & Co's JNJ Position: Q1 2026 in Review

Lord, Abbett & Co increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $35.5M and bringing the position to 1,482,192 shares worth $362M. The position accounts for 1.18% of the portfolio, ranked #10.

Lord, Abbett & Co first reported a position in JNJ in Q2 2013 and has held it in 39 quarters since. The position peaked at $443M in Q2 2016. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Lord, Abbett & Co held 1,482,192 shares of Johnson & Johnson worth $362M as of Q1 2026.
  • Lord, Abbett & Co bought 152,507 Johnson & Johnson shares in Q1 2026, an estimated $35.5M.
  • Johnson & Johnson made up 1.18% of Lord, Abbett & Co's portfolio in Q1 2026, its #10 holding.
  • Lord, Abbett & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 39 quarters since.
  • Lord, Abbett & Co's Johnson & Johnson position peaked at $443M in Q2 2016.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.